InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
7
Disclosed sells
1
T+90 hit rate
33%
T+90 mean return
+10.4%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Thorp Clay, Director. Director active across 4 companies, notably PhaseBio Pharmaceuticals Inc. Aggregated, 12 reports have been logged. Breakdown: 7 buys · 1 sell. Total volume traded: €283k. History available since 18 August 2021. The latest transaction was filed on 24 February 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
15,000 shares@ US$0.928.5% of flowCommon StockSEC:0001415889-25-005325:0
Ideal exit: 21 Nov 2025 (T+270)
10,000 shares@ US$0.865.7% of flowCommon StockSEC:0001209191-23-050480:0
Ideal exit: 21 Jun 2024 (T+270)
3,750 sharesCommon StockSEC:0001169245-23-000032:0
14,000 shares@ US$1.0198.7% of flowCommon StockSEC:0001209191-22-062338:0
Ideal exit: 17 Sept 2023 (T+270)
32,873 shares@ US$4.4377.6% of flowCommon StockSEC:0001209191-22-062044:0
1,406,507 shares0Common StockSEC:0001209191-22-062045:0
21,802 shares@ US$2.762274.6% of flowCommon StockSEC:0000899243-22-018491:0
Ideal exit: 10 Feb 2023 (T+270)
3,000 shares@ US$7.201425.4% of flowCommon StockSEC:0000899243-22-012485:0
Ideal exit: 23 Dec 2022 (T+270)
1,254,335 sharesCommon StockSEC:0000899243-22-001658
1,254,335 sharesCommon StockSEC:0000899243-22-001658:0
10,000 shares@ US$3.0050.0% of flowCommon StockSEC:0001169245-21-000080:0
Ideal exit: 15 May 2022 (T+270)
10,000 shares@ US$3.0050.0% of flowCommon StockSEC:0001169245-21-000080
Ideal exit: 15 May 2022 (T+270)
12 of 12 declarations
About Thorp Clay
Clay Thorp is a Board Member at PhaseBio Pharmaceuticals Inc and Vigil Neuroscience, Inc. He plays a key role in corporate governance, bringing his expertise in strategy and business development. His commitment to innovation is essential for guiding decisions within the boards.
